INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - BIT:1ISRG - US46120E6023 - Common Stock
400.6 EUR
+25.15 (+6.7%)
1ISRG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. This makes 1ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
1ISRG had positive earnings in the past year.
In the past year 1ISRG had a positive cash flow from operations.
Each year in the past 5 years 1ISRG has been profitable.
In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
1ISRG has a Return On Assets of 12.93%. This is amongst the best in the industry. 1ISRG outperforms 91.53% of its industry peers.
1ISRG has a better Return On Equity (14.61%) than 81.36% of its industry peers.
1ISRG has a better Return On Invested Capital (10.75%) than 84.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 9.04%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(10.75%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROIC | 10.75% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
1ISRG has a better Profit Margin (28.51%) than 96.61% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
Looking at the Operating Margin, with a value of 28.96%, 1ISRG belongs to the top of the industry, outperforming 98.31% of the companies in the same industry.
1ISRG's Operating Margin has declined in the last couple of years.
The Gross Margin of 1ISRG (66.61%) is better than 72.88% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
1ISRG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
1ISRG has an Altman-Z score of 44.99. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 44.99, 1ISRG belongs to the best of the industry, outperforming 98.31% of the companies in the same industry.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 44.99 |
ROIC/WACC1.24
WACC8.64%
2.3 Liquidity
A Current Ratio of 5.17 indicates that 1ISRG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.17, 1ISRG belongs to the best of the industry, outperforming 98.31% of the companies in the same industry.
A Quick Ratio of 4.18 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a better Quick ratio (4.18) than 98.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.97% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
The Revenue has grown by 20.77% in the past year. This is a very strong growth!
Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%
3.2 Future
The Earnings Per Share is expected to grow by 14.53% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.89% on average over the next years. This is quite good.
EPS Next Y13.54%
EPS Next 2Y13.54%
EPS Next 3Y14.49%
EPS Next 5Y14.53%
Revenue Next Year19.76%
Revenue Next 2Y17.08%
Revenue Next 3Y16.38%
Revenue Next 5Y14.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 57.72, which means the current valuation is very expensive for 1ISRG.
1ISRG's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.77. 1ISRG is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 49.21, which means the current valuation is very expensive for 1ISRG.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 64.41% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.23. 1ISRG is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.72 | ||
| Fwd PE | 49.21 |
4.2 Price Multiples
1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 66.10% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83.58 | ||
| EV/EBITDA | 49.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 14.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.26
PEG (5Y)5.03
EPS Next 2Y13.54%
EPS Next 3Y14.49%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (10/21/2025, 7:00:00 PM)
400.6
+25.15 (+6.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap143.61B
Revenue(TTM)9.14B
Net Income(TTM)2.61B
Analysts79
Price Target513.31 (28.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)2.06%
PT rev (3m)-0.3%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)1.72%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 57.72 | ||
| Fwd PE | 49.21 | ||
| P/S | 18.23 | ||
| P/FCF | 83.58 | ||
| P/OCF | 58.98 | ||
| P/B | 9.34 | ||
| P/tB | 9.54 | ||
| EV/EBITDA | 49.39 |
EPS(TTM)6.94
EY1.73%
EPS(NY)8.14
Fwd EY2.03%
FCF(TTM)4.79
FCFY1.2%
OCF(TTM)6.79
OCFY1.7%
SpS21.98
BVpS42.89
TBVpS42.01
PEG (NY)4.26
PEG (5Y)5.03
Graham Number81.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROCE | 14.34% | ||
| ROIC | 10.75% | ||
| ROICexc | 15.26% | ||
| ROICexgc | 15.7% | ||
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% | ||
| FCFM | 21.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 144.66% | ||
| Cap/Sales | 9.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.68% | ||
| Profit Quality | 76.48% | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 44.99 |
F-Score6
WACC8.64%
ROIC/WACC1.24
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
EPS Next Y13.54%
EPS Next 2Y13.54%
EPS Next 3Y14.49%
EPS Next 5Y14.53%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%
Revenue Next Year19.76%
Revenue Next 2Y17.08%
Revenue Next 3Y16.38%
Revenue Next 5Y14.89%
EBIT growth 1Y34.8%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%